Clinical Trials on Malignant Rhabdoid Tumor
Total 19626 results
-
Lokon Pharma ABPrecision Oncology LLCCompletedMalignant MelanomaSweden, United States
-
Immodulon Therapeutics LtdTerminatedMalignant MelanomaUnited Kingdom
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Linkoeping UniversityKarolinska Institutet; Region Östergötland; Region Stockholm; Kronoberg County... and other collaboratorsCompleted
-
Ludwig Institute for Cancer ResearchTerminated
-
Ludwig Institute for Cancer ResearchCancer Research Institute (CRI)CompletedMalignant MelanomaUnited States
-
Ludwig Institute for Cancer ResearchTerminated
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia, Brazil, Spain, South Africa, Ukraine, Bosnia and Herzegovina
-
Ultimovacs ASAOslo University HospitalActive, not recruiting
-
University of Kansas Medical CenterCompletedMalignant MelanomaUnited States
-
University of BaselUniversity Hospital, Basel, SwitzerlandCompletedMalignant Melanoma
-
Guangzhou Bioseal Biotechnology Co., Ltd.CompletedMalignant Tumors | Vascular Malformation | Benign TumorsChina
-
CelgenePrologue Research InternationalCompleted
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Milton S. Hershey Medical CenterCompletedMalignant MelanomaUnited States
-
Skin Analytics LimitedCompleted
-
University of ArizonaTerminatedMalignant MelanomaUnited States
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownMalignant MelanomaChina
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Hoffmann-La RocheCompleted
-
University of California, DavisCompletedMelanoma | Malignant MelanomaUnited States
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
University Hospital TuebingenGerman Research FoundationCompleted
-
AstraZenecaCompleted
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Bristol-Myers SquibbCompletedMalignant MelanomaUnited States
-
SentoClone ABUnknownMalignant MelanomaSweden
-
Royal Marsden NHS Foundation TrustUnknown
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Henry FriedmanCompletedGrade IV Malignant GliomaUnited States
-
Annick DesjardinsAmgenTerminated
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Recurrent Neuroblastoma | Recurrent Osteosarcoma | Hepatoblastoma | Recurrent Childhood Rhabdomyosarcoma | Recurrent Childhood Kidney Neoplasm | Previously Treated Childhood Rhabdomyosarcoma | Recurrent Childhood... and other conditionsUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedTesticular Germ Cell Tumor | Ovarian Cancer | Brain and Central Nervous System Tumors | Teratoma | Extragonadal Germ Cell TumorUnited States
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
Universitätsklinikum Hamburg-EppendorfCompletedEpendymoma | Medulloblastoma, Childhood | Cerebral Primitive Neuroectodermal TumorGermany
-
Children's National Research InstituteRecruitingAstroblastoma | BCOR ITD Sarcoma | CNS Sarcoma | Unclassified Tumor, MalignantUnited States
-
Universitätsklinikum Hamburg-EppendorfCompletedBrain and Central Nervous System TumorsGermany
-
Children's Hospital Los AngelesNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States, Canada
-
Centre Leon BerardTransgeneCompletedAdvanced Tumor | Metastatic TumorFrance
-
IpsenCompletedNeuroendocrine Tumors | Carcinoid SyndromeFrance, Italy, United Kingdom, Poland, Spain, Hungary, Czechia, Israel
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisTerminatedNeuroendocrine CarcinomaUnited States
-
Novo Nordisk A/SCompleted
-
Hoffmann-La RocheWithdrawn
-
Italian Network for Tumor BiotherapyBristol-Myers SquibbCompletedMetastatic Malignant MelanomaItaly
-
NYU Langone HealthCompletedMetastatic Malignant Melanoma
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States